Opamox (Oxazepam)

Oxazepam, the active ingredient in Opamox, is a benzodiazepine presented as a tablet for oral use. It is prescribed for the short‑term management of anxiety disorders and related symptoms in adults.

GNH USA supplies Opamox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxazepam belongs to the benzodiazepine class and is used to treat conditions that involve excessive central nervous system excitation. - Anxiety disorder: Reduces tension‑related psychological and somatic symptoms. - Acute alcohol withdrawal: Alleviates tremor, agitation and risk of seizures. - Pre‑operative sedation: Provides calming effect before surgical procedures.

Oxazepam may cause a range of adverse reactions, most of which are dose‑dependent and reversible upon discontinuation.

Common Side Effects: - Drowsiness - Dizziness - Headache - Fatigue - Nausea - Impaired coordination

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Paradoxical aggression or agitation - Hallucinations - Skin reactions such as Stevens‑Johnson syndrome - Hepatic dysfunction

When prescribing Oxazepam, clinicians should consider several safety aspects to minimise risk. - Pregnancy: Use only if clearly needed; potential teratogenic risk. - Breastfeeding: May pass into milk; evaluate benefit‑risk. - Elderly patients: Start low, monitor for falls and confusion. - Concomitant CNS depressants: Avoid additive sedation. - History of substance misuse: Assess dependence potential. - Store at ambient temperature: keep in original packaging, protect from moisture.

Oxazetan...